Jeffrey A Medin

Ontario Cancer Institute

$1,449,192

Attributed

$1,449,192

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $175.9K · FY2005–14

$200K$150K$100K$50K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

Funding mix

By agency

NIH$1,449,192 · 3

By mechanism

R01$800,000 · 1

R21$649,192 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Gene Therapy”

David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
Randall J Bateman · Washington University$122,781,098
Eric Martin McDade · Washington University$94,632,845
Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
Robert B. Diasio · University Of Alabama At Birmingham$73,470,685

Research focus

Gene TherapyTransfection /Expression VectorCarbohydrate ReceptorFabry'S DiseaseEnzyme MechanismCofactorReceptor Mediated EndocytosisLaboratory MouseRecombinant ProteinsNonhuman Therapy EvaluationAlpha GalactosidaseCell LineHematopoietic Tissue TransplantationAnimalsBone Marrow TransplantationGranulomaHydrolaseFarber&AposCellsBone MarrowAnimal ModelEnzyme Replacement TherapyGalactosylgalactosylglucosylceramidaseComplex